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Background: NVAF patients with a CHADS2 score of 1 includes a heterogeneous group of patients. We sought to investigate whether this score 
could predict the occurrence of a composite cardiovascular (CV) endpoint including death, stroke and heart failure (HF) when considering separately 
each of the clinical parameter.
Methods: 541 patients with AF were consecutively included in a single-center and followed-up for a mean of 1.76 ± 1.43 years. For the purpose of 
this analysis, only patients with a CHADS2 score of 1 (n=136) were considered.
Results: The mean age was 63.1±11.4, 35 patients (25.7%) were aged > 75 y, 68 (55.1%) had hypertension, 14 (10.3%) had diabetes and 19 
(14.0%) a history of heart failure. The rate of death was 7.4 % in patients with a CHADS2 score = 1 defined by hypertension, 20.0 %, when age > 75 
y, 42.0% when defined by a history of heart failure and 0% when only diabetes was present (p<0.0001). At follow-up, the corresponding figures for 
the occurrence of stroke were 4.4%, 2.9%, 5.3 and 0%, respectively (p=0.989) and for the occurrence of heart failure 26.5%, 5.7%, 15.8% and 7.1%, 
respectively)
Based on unadjusted Kaplan-Meier plots, representing patients with a score of 0, 1 due to HF and 1 due to another risk marker, those with a 
CHADS2 = 1 due to HF had the worst prognosis (figure, p<0.001)).
Conclusion: The risk of CV events is higher in AF patients with a CHADS2 risk score = 1 defined by a history of 
heart failure, as compared to patients with the same score due to another risk marker of theromboembolism.
